Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fixed vs Weight-Based Plerixafor in NHL
NCT01164475Phase 4Completed
- Sponsor
- Sanofi
- Start
- Oct 2010
- Primary completion
- Feb 2013
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 4 trial of plerixafor in Non-Hodgkin lymphoma (NHL), sponsored by Sanofi. Started Oct 2010; status: completed.
02
Drugs
plerixafor
03
Conditions
Non-Hodgkin lymphoma (NHL)
Beyond the preview
Go deeper on NCT01164475.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01164475.